Laboratory News and Research

RSS

Replace your tedious routine with the more relaxed weigh-in experience of the new XPR Analytical balance from METTLER TOLEDO

METTLER TOLEDO is pleased to support your needs for an accurate, intuitive weighing experience with the launch of our newly redesigned XPR Analytical balance.

From Mettler-Toledo International Inc. 5 May 2020

Customizing access rights on balances improves productivity: Find out how with a free application note from METTLER TOLEDO

On a daily basis, labs usually carry out routine applications that can benefit from simplification. However, new users or those who repeat operations many times a shift may place special value on ease-of-use and procedural time-savings.

From Mettler-Toledo International Inc. 5 May 2020

Innovative crystal has many promising applications

Spinels are oxides with chemical formulas of the type AB2O4, where A is a divalent metal cation (positive ion), B is a trivalent metal cation, and O is oxygen.

5 May 2020

Loss of smell may be related to neuroinvasive propensity of SARS-CoV-2

The novel coronavirus has rapidly infected millions over the world in over 187 countries and territories, causing hundreds of thousands of deaths. One of the often-neglected and under-reported symptoms of the virus is the loss of the sense of smell or anosmia. Now, a new study out of Germany published on the preprint server medRxiv in April 2020 provides a quantified estimate of the magnitude of anosmia as a symptom of the coronavirus.

4 May 2020

MU researcher finds four antiviral drugs effective in inhibiting novel coronavirus

Now, a researcher at the University of Missouri has found that four antiviral drugs, including remdesivir, a drug originally developed to treat Ebola, are effective in inhibiting the replication of the coronavirus causing COVID-19.

4 May 2020

Study suggests ROBO2 pathway as therapeutic target for kidney diseases

Researchers have published a new study that suggests a signaling pathway called ROBO2 is a therapeutic target for kidney diseases, specifically kidney podocyte injury and glomerular diseases.

4 May 2020

Testing in California still a frustrating patchwork of haves and have-nots

Months into the spread of the coronavirus in the United States, widespread diagnostic testing still isn't available, and California offers a sobering view of the dysfunction blocking the way.

4 May 2020

Scientists identify key neurological modifications following sustained exercise

Doctors have relentlessly impressed upon us the many benefits of exercise. Energy, mood, sleep and motor skills all improve with a regular fitness regimen that includes activities such as running. T

4 May 2020

New antibiotic fights drug-resistant bacteria without notable toxic side-effects

Through serendipity, researchers at the University of Pittsburgh Graduate School of Public Health considerably reduced the toxicity of a potential antibiotic against the most feared drug-resistant bacteria, while also improving its stability in fighting infections.

4 May 2020

Eco-friendly technique could enable hospitals to produce hydrogen peroxide

A team of researchers has developed a portable, more environmentally friendly method to produce hydrogen peroxide. It could enable hospitals to make their own supply of the disinfectant on demand and at lower cost.

4 May 2020

How mistakes help stabilize the continually changing impressions of the environment

Our short-term memory is wired to deceive people on purpose, and a new study explains why. For instance, when people look at the same object twice, the second glance reflects a slightly different image, which are the workings of short-term memory as it makes a systematic mistake.

4 May 2020

Certain scores can predict susceptibility of trauma patients to multiple infections

Trauma patients are at risk of developing multiple infections while in the hospital, but it's difficult to identify those who are especially susceptible.

4 May 2020

Rapid affordable viral testing kits for low-resource settings

A new paper published on the preprint server bioRxiv* in April 2020 reports a low-cost, sensitive and rapid RT-PCR testing kit for the detection of COVID-19. If validated, this could provide an enormous boost to diagnostic testing in low-resource regions of the world.

4 May 2020

Research reveals mechanism underlying Parkinson's dyskinesia

Many people with Parkinson's disease eventually develop debilitating movements called dyskinesia, a side effect of their much-needed dopamine replacement medication.

3 May 2020

EPFL computer scientists test and refine proximity tracing app

Over the past two weeks, EPFL computer scientists have been testing and refining the smartphone-based system developed by the international Decentralized Privacy-Preserving Proximity Tracing project, with the help of the Swiss Army.

2 May 2020

AHA awards grants to 12 teams for fast-tracked heart and brain health research related to COVID-19

Less than a month after issuing a rapid response call for scientific research proposals for fast-tracked studies of the effects of COVID-19 on the body's cardiovascular and cerebrovascular systems, the American Heart Association has awarded $1.2 million in grants to teams at 12 institutions across the U.S. to begin this unprecedented work.

2 May 2020

Lipo-ImmunoTech receives grant to develop novel adoptive cell therapy technology for cancer

Lipo-ImmunoTech, LLC, a startup based in Charleston, South Carolina, recently received a Phase I Small Business Technology Transfer grant of just over $224,000 to continue to develop its novel adoptive cell therapy technology for cancer.

2 May 2020

UBC discovery could pave way for developing new anti-malarial drugs

For the first time, UBC researchers have shown a key difference in the three-dimensional structures of a key metabolic enzyme in the parasite that causes malaria compared to its human counterpart.

2 May 2020

Study finds potential new therapeutic targets for childhood brain tumors

People with the genetic condition neurofibromatosis type 1 (NF1) are prone to developing tumors on nervous system tissue.

2 May 2020

Combination of schizophrenia drug and radiation shows promise in treating glioblastoma

Researchers at the UCLA Jonsson Comprehensive Cancer Center and colleagues have found that adding a drug once commonly used to treat schizophrenia to traditional radiation therapy helped improve overall survival in mice with glioblastoma, one of the deadliest and most difficult-to-treat brain tumors.

2 May 2020

Laboratory News and Research

Replace your tedious routine with the more relaxed weigh-in experience of the new XPR Analytical balance from METTLER TOLEDO

Customizing access rights on balances improves productivity: Find out how with a free application note from METTLER TOLEDO

Innovative crystal has many promising applications

Loss of smell may be related to neuroinvasive propensity of SARS-CoV-2

MU researcher finds four antiviral drugs effective in inhibiting novel coronavirus

Study suggests ROBO2 pathway as therapeutic target for kidney diseases

Testing in California still a frustrating patchwork of haves and have-nots

Scientists identify key neurological modifications following sustained exercise

New antibiotic fights drug-resistant bacteria without notable toxic side-effects

Eco-friendly technique could enable hospitals to produce hydrogen peroxide

How mistakes help stabilize the continually changing impressions of the environment

Certain scores can predict susceptibility of trauma patients to multiple infections

Rapid affordable viral testing kits for low-resource settings

Research reveals mechanism underlying Parkinson's dyskinesia

EPFL computer scientists test and refine proximity tracing app

AHA awards grants to 12 teams for fast-tracked heart and brain health research related to COVID-19

Lipo-ImmunoTech receives grant to develop novel adoptive cell therapy technology for cancer

UBC discovery could pave way for developing new anti-malarial drugs

Study finds potential new therapeutic targets for childhood brain tumors

Combination of schizophrenia drug and radiation shows promise in treating glioblastoma

Pittcon 2024 - Advancing Science on the West Coast eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo